Mariana Peixoto Socal

Research output

Research output per year 2001 2019 2020 2021 2022 2023 2024

• 48 Article
• 10 Letter
• 8 Comment/debate
• 6 Review article
• 5 More
  • 4 Editorial
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2024

  Addressing the Drug-Shortage Crisis in Oncology

  Yang, Y. T., Socal, M. & Bennett, C. L., Feb 15 2024, In: JAMA Oncology. 10, 2, p. 155-156 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates

  Costin, J., Mouslim, M. C., Socal, M. P. & Trujillo, A., Jan 2024, In: PharmacoEconomics - Open. 8, 1, p. 115-118 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Health Insurance Plan 100%
  • Biosimilar Pharmaceuticals 91%
  • health plan 80%
  • Health Insurance 69%
  • health maintenance organizations 45%

• Ownership and Interoperability Challenges of Alzheimer Monoclonal Antibody Registries

  Peixoto Socal, M., Odouard, I. C. & Kharrazi, H., Feb 12 2024, In: JAMA Neurology. 81, 2, p. 109-110 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Pediatric Drugs, Accelerated Approval, and Prospects for Reform

  Ballreich, J., Kim, H. S. & Socal, M., Jan 2024, In: Pediatric Drugs. 26, 1, p. 5-8 4 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Spending on Dual Over-the-Counter and Prescription Drugs in the Medicare Part D Program

  Socal, M., Wang, Y., Plummer, E., Anderson, G. F. & Bai, G., Jan 2 2024, In: JAMA. 331, 1, p. 72-75 4 p.

  Research output: Contribution to journal › Article › peer-review
• 2023

  Accelerated approval drug labels often lack information for clinical decision-making

  Ballreich, J., Socal, M., Bennett, C. L., Xuan, A., Trujillo, A. & Anderson, G., Apr 2023, In: Pharmacotherapy. 43, 4, p. 300-304 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug Approval 100%
  • Clinical Decision-Making 81%
  • Pharmaceutical Preparations 32%
  • Biomarkers 25%
  • United States Food and Drug Administration 9%

• Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-based Lifestyle Interventions

  Zhang, M., Zucatti, K. P., Teixeira, P. P., Correia, P. E., Wayerbacher, L. F., Spiazzi, B. F., Socal, M. P., Boyko, E. J., Colpani, V. & Gerchman, F., Jul 14 2023, In: The Journal of clinical endocrinology and metabolism. 108, 8, p. 2124-2133 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Prediabetic State 82%
  • Life Style 52%
  • Type 2 Diabetes Mellitus 48%
  • Population 25%
  • Neoplasms 20%

• Competition And Vulnerabilities In The Global Supply Chain For US Generic Active Pharmaceutical Ingredients

  Socal, M. P., Ahn, K., Greene, J. A. & Anderson, G. F., Mar 2023, In: Health Affairs. 42, 3, p. 407-415 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Generic Drugs 100%
  • pharmaceutical 67%
  • Pharmaceutical Preparations 30%
  • drug 14%
  • Data Science 11%

• Developing Prioritization Criteria to Identify Target Drugs for CalRx, the California Generic Drugs Initiative

  Socal, M. P., Estus, E., Long, J., Crane, M. A., Pegany, V. & Anderson, G. F., May 2023, In: Value in Health. 26, 5, p. 634-638 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Generic Drugs 100%
  • drug 49%
  • Pharmaceutical Preparations 30%
  • Costs and Cost Analysis 18%
  • Weights and Measures 15%

• Estimating Changes in Medicare Part D and Commercial Insurer Insulin Spending Amid Planned State-Led Biosimilar Insulin Production in California

  Anderson, K. E., Xuan, A., Anderson, G. F. & Socal, M. P., Jul 3 2023, In: JAMA internal medicine. 183, 7, p. 734-735 2 p.

  Research output: Contribution to journal › Article › peer-review

• Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019

  Liu, A., Xuan, A., Socal, M., Anderson, G. & Anderson, K. E., Jan 2023, In: Journal of Managed Care and Specialty Pharmacy. 30, 1, p. 15-21 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Medicare Part C 100%
  • Filgrastim 90%
  • Biosimilar Pharmaceuticals 88%
  • health maintenance organizations 87%
  • Infliximab 74%

• Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs

  Anderson, K. E., DiStefano, M. J., Liu, A., Mattingly, T. J., Socal, M. P. & Anderson, G. F., Sep 2023, In: Value in Health. 26, 9, p. 1381-1388 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Medicare 100%
  • pricing 96%
  • drug 65%
  • Costs and Cost Analysis 60%
  • Pharmaceutical Preparations 40%

• Increasing Private Payer and Medicare Coverage of Circulating Tumor DNA Tests: What’s at Stake?

  Socal, M. P., Jun 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 6, p. 685-686 2 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Insulins and the Evolving Landscape of U.S. Prescription Drug Pricing

  Socal, M. P. & Bai, G., Sep 1 2023, In: Annals of internal medicine. 176, 9, p. 1259-1261 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Response to Letter to the Editor From Stumpf et al: Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-Based Lifestyle Interventions

  Zhang, M., Zucatti, K. P., Teixeira, P. P., Spiazzi, B. F., Correia, P. E., Wayerbacher, L. F., Socal, M. P., Boyko, E. J., Colpani, V. & Gerchman, F., Oct 18 2023, In: The Journal of clinical endocrinology and metabolism. 108, 11, p. e1461-e1462

  Research output: Contribution to journal › Editorial › peer-review

• Role of Registries in Medicare Coverage of New Alzheimer Disease Drugs

  Odouard, I. C., Socal, M. P. & Anderson, G. F., Oct 10 2023, In: JAMA. 330, 14, p. 1331-1332 2 p.

  Research output: Contribution to journal › Short survey › peer-review
• 2022

  Anticipating Reforms to the Prescription Drug User Fees Act

  Ballreich, J., Socal, M. & Anderson, G. F., Nov 1 2022, In: JAMA Network Open. 5, 11, p. e2239341

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Estimating Savings Opportunities from Therapeutic Substitutions of High-Cost Generic Medications

  Socal, M. P., Cordeiro, T., Anderson, G. F. & Bai, G., Nov 2 2022, In: JAMA Network Open. 5, 11, p. E2239868

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug Substitution 100%
  • Income 56%
  • Costs and Cost Analysis 42%
  • Generic Drugs 16%
  • Insurance Carriers 15%

• Impacts of the 2017 Brazilian National Primary Care Policy on public primary health care in Rio de Janeiro, Brazil

  Garcia, F. L. & Socal, M., 2022, In: Cadernos de saude publica. 38, 5, e00219421.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Brazil 100%
  • Primary Health Care 86%
  • Family Health 84%
  • health care 78%
  • Public Health 78%

• Manufacturer-Sponsored Cost-Sharing Programs for Insulin: Are Patients Getting the Help They Need?

  Fraker, J. H. & Socal, M. P., May 2022, In: Journal of general internal medicine. 37, 6, p. 1561-1564 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Measuring and Mitigating Gender-Based Disparities in Earning Potential in Academic Medicine

  Socal, M. P., Liu, A. & Anderson, G. F., Feb 18 2022, In: JAMA Network Open. 5, 2, e220074.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Medicare Spending on Drugs With Accelerated Approval

  Ballreich, J., Socal, M., Bennett, C. L., Schoen, M. W., Trujillo, A., Xuan, A. & Anderson, G., Jul 1 2022, In: Annals of internal medicine. 175, 7, p. 938-944 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Medicare 100%
  • Pharmaceutical Preparations 40%
  • Fee-for-Service Plans 38%
  • Medicare Part B 23%
  • Drug Approval 19%

• Misinformation in nutrition through the case of coconut oil: An online before-and-after study

  Duarte, A. C., Spiazzi, B. F., Merello, E. N., Amazarray, C. R., Sulzbach de Andrade, L., Socal, M. P., Trujillo, A. J., Brietzke, E., Colpani, V. & Gerchman, F., Jun 2022, In: Nutrition, Metabolism and Cardiovascular Diseases. 32, 6, p. 1375-1384 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Coconut Oil 100%
  • Communication 48%
  • Insurance Benefits 12%
  • Health Literacy 7%
  • Social Networking 6%

• State-level policy efforts to regulate pharmacy benefit managers (PBMs)

  Mattingly, T. J., Lewis, M., Socal, M. P. & Bai, G., Nov 2022, In: Research in Social and Administrative Pharmacy. 18, 11, p. 3995-4002 8 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Prescription Drug 100%
  • Pharmacy 59%
  • Transparency 29%
  • Prescription Drugs 23%
  • Pharmacies 22%

• The Price Paradox of Biosimilar-Like Long-Acting Insulin

  Mouslim, M. C., Rashidi, E. S., Levy, J. F., Socal, M. P. & Trujillo, A. J., Nov 2022, In: American Journal of Managed Care. 28, 11, p. E405-E410

  Research output: Contribution to journal › Article › peer-review

  • Long-Acting Insulin 100%
  • Insulin Glargine 93%
  • Biosimilar Pharmaceuticals 92%
  • costs 37%
  • Health Expenditures 30%

• Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?

  Trujillo, A. J., Gutierrez, J. C., Garcia Morales, E. E., Socal, M., Ballreich, J. & Anderson, G., Dec 2022, In: Health Economics Review. 12, 1, 37.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Generic Drugs 100%
  • drug 49%
  • market 40%
  • drug list 15%
  • competitive market 11%

• Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019

  Plummer, E., Socal, M. P., Ballreich, J. M., Anderson, G. F. & Bai, G., May 6 2022, In: JAMA Health Forum. 3, 5, e220888.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• When States Step Up: California and the Case for State-Led Insulin Manufacturing

  Socal, M. P., Pegany, V. & Ghaly, M., Dec 1 2022, In: Annals of internal medicine. 175, 12, p. 1756-1758 3 p.

  Research output: Contribution to journal › Article › peer-review
• 2021

  Association between Waste-Free Formularies and Prescription Drug Spending among Self-insured Employers

  Socal, M. P., Bai, G., Cordeiro, T. & Anderson, G. F., Oct 28 2021, In: JAMA Network Open. 4, 10, e2131486.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Biosimilar formulary placement in Medicare Part D prescription drug plans: A case study of infliximab

  Socal, M. P., Ezebilo, I., Bai, G. & Anderson, G. F., Feb 1 2021, In: American Journal of Health-System Pharmacy. 78, 3, p. 216-221 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Prescription Drug 100%
  • Medicare Part D 92%
  • Biosimilar Pharmaceuticals 82%
  • Formularies 79%
  • Prescription Drugs 69%

• Bipartisan Federal Legislation to Address Insulin Access and Affordability

  Socal, M. P. & Bai, G., Nov 2021, In: Diabetes Spectrum. 34, 4, p. 394-398 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Legislation 100%
  • Insulin 62%
  • Costs and Cost Analysis 57%
  • Cost Sharing 46%
  • Biosimilar Pharmaceuticals 42%

• Changes Associated with the Entry of a Biosimilar in the Insulin Glargine Market

  Levy, J., Chowdhury, Z. M., Socal, M. P. & Trujillo, A. J., Oct 2021, In: JAMA internal medicine. 181, 10, p. 1405-1407 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Factors Associated with Prescriptions for Branded Medications in the Medicare Part D Program

  Socal, M. P., Bai, G. & Anderson, G. F., Mar 2 2021, In: JAMA Network Open. 4, 3, p. E210483

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Medicare Part D 100%
  • Prescriptions 53%
  • Medicare 27%
  • Pharmaceutical Preparations 17%
  • Health Expenditures 10%

• Off-Label Coverage of High-Cost Drugs by Independent Charity Patient Assistance Programs

  Kang, S. Y., Socal, M. P., Bai, G. & Anderson, G. F., Feb 2021, In: Journal of general internal medicine. 36, 2, p. 555-556 2 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions

  Southern Network on Adverse Reactions, Aug 2021, In: The Lancet Haematology. 8, 8, p. e593-e604

  Research output: Contribution to journal › Review article › peer-review

  • Progressive Multifocal Leukoencephalopathy 100%
  • Rituximab 78%
  • B-Cell Chronic Lymphocytic Leukemia 22%
  • Non-Hodgkin's Lymphoma 19%
  • Microscopic Polyangiitis 15%

• The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution

  Socal, M. P., Sharfstein, J. M. & Greene, J. A., Apr 2021, In: American journal of public health. 111, 4, p. 635-639 5 p.

  Research output: Contribution to journal › Editorial › peer-review

• The Role of Advance Purchasing Commitments in Government Drug Price Negotiations: Lessons From the COVID-19 Response

  Socal, M. P. & Anderson, G. F., Apr 2021, In: American journal of public health. 111, 4, p. 652-657 6 p.

  Research output: Contribution to journal › Editorial › peer-review

• Variability of COPD inhaler coverage in medicare Part D

  Wormser, B., Socal, M. P. & Anderson, G., May 2021, In: American Journal of Managed Care. 27, 5, p. 187-193 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Medicare Part D 100%
  • Nebulizers and Vaporizers 75%
  • Prescription Drugs 75%
  • Chronic Obstructive Pulmonary Disease 57%
  • coverage 48%
• 2020

  Barriers to biosimilar utilization in the United States

  Dalpoas, S. E., Socal, M., Proctor, C. & Shermock, K. M., Dec 1 2020, In: American Journal of Health-System Pharmacy. 77, 23, p. 2006-2014 9 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Biosimilar Uptake in Medicare Part B Varied Across Hospital Outpatient Departments and Physician Practices: The Case of Filgrastim

  Socal, M. P., Anderson, K. E., Sen, A., Bai, G. & Anderson, G. F., Apr 2020, In: Value in Health. 23, 4, p. 481-486 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Medicare Part B 100%
  • hospital outpatients 99%
  • Filgrastim 89%
  • Biosimilar Pharmaceuticals 86%
  • Hospital Departments 68%
  5 Scopus citations

• Critical drugs for critical care: Protecting the us pharmaceutical supply in a time of crisis

  Socal, M. P., Sharfstein, J. M. & Greene, J. A., Sep 2020, In: American journal of public health. 110, 9, p. 1346-1347 2 p.

  Research output: Contribution to journal › Editorial › peer-review

• Interchangeable insulins - New pathways for safe, effective, affordable diabetes therapy

  Socal, M. P. & Greene, J. A., Mar 12 2020, In: New England Journal of Medicine. 382, 11, p. 981-983 3 p.

  Research output: Contribution to journal › Review article › peer-review

  • Insulins 100%
  • Insulin 47%
  • Marketing 37%
  • Therapeutics 11%
  2 Scopus citations

• Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US

  Padula, W. V., Parasrampuria, S., Socal, M. P., Conti, R. M. & Anderson, G. F., Oct 1 2020, In: PharmacoEconomics. 38, 10, p. 1115-1121 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Orphan Drug Production 100%
  • orphan 79%
  • Budgets 75%
  • budget 52%
  • drug 45%
  4 Scopus citations

• Modifying the Criteria for Granting Orphan Drug Market Exclusivity

  Socal, M. P., Parasrampuria, S. & Anderson, G. F., Nov 2020, In: Value in Health. 23, 11, p. 1470-1476 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Orphan Drug Production 100%
  • orphan 79%
  • drug 45%
  • market 37%
  • Pharmaceutical Preparations 27%
  1 Scopus citations

• Naming Convention, Interchangeability, and Patient Interest in Biosimilars

  Socal, M. P., Garrett, J. B., Tayler, W. B., Bai, G. & Anderson, G. F., Aug 1 2020, In: Diabetes Spectrum. 33, 3, p. 273-279 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Biosimilar Pharmaceuticals 100%
  • benzoylprop-ethyl 31%
  • Biological Products 18%
  • Prescriptions 16%
  • Names 13%

• Occupational pesticide exposure and the risk of death in patients with Parkinson's disease: An observational study in southern Brazil

  Schneider Medeiros, M., P. Reddy, S., P. Socal, M., Schumacher-Schuh, A. F. & Mello Rieder, C. R., Jun 17 2020, In: Environmental Health: A Global Access Science Source. 19, 1, 68.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pesticides 100%
  • Occupational Exposure 95%
  • Pesticide 83%
  • Brazil 81%
  • Parkinson Disease 75%

• Older Americans' preferences between lower drug prices and prescription drug plan choice, 2019

  Socal, M. P. & Anderson, G. F., 2020, In: American journal of public health. 110, 3, p. 354-356 3 p.

  Research output: Contribution to journal › Review article › peer-review

  • Drug Prescriptions 100%
  • Prescription Drugs 96%
  • medication 70%
  • drug 55%
  • Pharmaceutical Preparations 33%

• Patient Narratives: a Tool for People-Centered Health Systems Education

  Socal, M. P., Dec 2020, In: Medical Science Educator. 30, 4, p. 1437-1443 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Health Education 100%
  • education system 83%
  • Students 61%
  • narrative 61%
  • health 45%

• Patient Selection After Mandatory Bundled Payments for Hip and Knee Replacement: Limited Evidence of Lemon-Dropping or Cherry-Picking

  Humbyrd, C. J., Wu, S. S., Trujillo, A. J., Socal, M. P. & Anderson, G. F., Feb 19 2020, In: Journal of Bone and Joint Surgery. 102, 4, p. 325-331 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Patient Selection 100%
  • Hip 94%
  • Knee 91%
  • Hemiarthroplasty 41%
  • Medicare 31%
  5 Scopus citations

• Reply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US”

  Padula, W. V., Parasrampuria, S., Socal, M. P., Conti, R. M. & Anderson, G. F., Dec 2020, In: PharmacoEconomics. 38, 12, p. 1375-1376 2 p.

  Research output: Contribution to journal › Letter › peer-review